Did anyone consider the div of abbv @ over 4%. At this rate it is worth keep. This stock pays you to ride it out. But I also think abt will have good earing and play chatch up to abbv. We ae looling at two $40 stocks here.
Although Cramer is wrong more than not, I think his recommendation of ABT over ABBV was a sound one. I guess what's happening is the funds holding the old ABT as a pharmaceutical are offloading the new ABT since it's no longer in that criteria. ABBV however is. Give it a few months and ABT should shoot past ABBV.